Company News

Oxford Vacmedix and CHAIN Biotech collaborate to develop oral vaccines

Company News / 3rd January 2021

Oxford Vacmedix and CHAIN Biotech have signed Heads of Terms for a Collaboration Agreement to develop and commercialise oral vaccines targeting cancer & infectious disease Oxford, UK – 4th January 2020 – FOR IMMEDIATE RELEASE Press Release – OVM CHAIN Collaboration Oxford 4th Jan 2020; Oxford Vacmedix (OVM), the UK based biopharma company, focused on …

Oxford Vacmedix and CHAIN Biotech collaborate to develop oral vaccines Read More »

Oxford Vacmedix announces filing of new patent for Covid-19 vaccine and diagnostics

Company News / 18th November 2020

New patent using Recombinant Overlapping Peptide (ROP technology) as novel approach to SARS-Cov-2 pandemic filed, after rapid development and initial testing Oxford, UK – 24th November 2020 – FOR IMMEDIATE RELEASE Press Release-Patent filed for Covid-19 vaccine and diagnostics 24-11-20 Oxford 24th November 2020; Oxford Vacmedix (OVM), the UK based biopharma company, focused on the …

Oxford Vacmedix announces filing of new patent for Covid-19 vaccine and diagnostics Read More »

Oxford Vacmedix founder Dr Shisong Jiang appointed as Senior Industrial Fellow at University of Oxford

Company News / 9th November 2020

Shisong Jiang is appointed to the newly created role of Senior Industrial Fellow in the Department of Oncology at the University of Oxford Oxford, UK – 9th November 2020 – FOR IMMEDIATE RELEASE Download PDF – Press Release-Senior Industrial Fellow 09-11-20 Oxford 9th November 2020; Oxford Vacmedix (OVM), the UK based biopharma company, focused on …

Oxford Vacmedix founder Dr Shisong Jiang appointed as Senior Industrial Fellow at University of Oxford Read More »